Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_assertion type Assertion NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_head.
- NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_assertion description "[The aim of this study was to evaluate the regulation of RKIP and STAT3 after treatment with clinically relevant chemotherapeutic agents (camptothecin (CPT) and oxaliplatin (OXP)) and the cytokine interleukin-6 (IL-6) in HCT116 colon cancer cells as well as evaluate the association between RKIP and STAT3 with clinical outcome of Stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_provenance.
- NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_assertion evidence source_evidence_literature NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_provenance.
- NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_assertion SIO_000772 24098947 NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_provenance.
- NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_assertion wasDerivedFrom befree-2016 NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_provenance.
- NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_assertion wasGeneratedBy ECO_0000203 NP1116732.RAiM2Sdzgo3N6_PmhyAW2ujRGEtr8FQDnAXxU99xr0XxM130_provenance.